Palomino Laboratories Inc.
PALX
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 133,641.67% | 44,300.00% | 44,300.00% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 133,641.67% | 44,300.00% | 44,300.00% | ||
| Operating Income | -133,641.67% | -44,300.00% | -44,300.00% | ||
| Income Before Tax | -28,865.08% | -- | -298,000.00% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -28,865.08% | -- | -298,000.00% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -28,865.08% | -- | -298,000.00% | ||
| EBIT | -133,641.67% | -44,300.00% | -44,300.00% | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | -14,092.11% | -- | -- | ||
| Normalized Basic EPS | -13,941.67% | -- | -- | ||
| EPS Diluted | -14,092.11% | -- | -- | ||
| Normalized Diluted EPS | -13,941.67% | -- | -- | ||
| Average Basic Shares Outstanding | 103.60% | 93.86% | 93.86% | ||
| Average Diluted Shares Outstanding | 103.60% | -46.54% | -46.54% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||